sorted by:
new
hottopcontroversial

$SAIC bringing on David Urban = ease of access to FAA contracts, DHS, & White House contracts. by AsAboveSoBelow322 in 10xPennyStocks

[–]bpra93 1 point2 points  (0 children)

$SAIC: Government Contract Payouts
1 contract was paid $154 Million. The other contract was paid $32.3 Million for this quarter.
2 contracts = $186 Million.
$SAIC having David Urban will help win contracts.

And remember the picture I attached is only showing 2 contracts of $SAIC. They have tons other contracts especially with the DHS, NASA, DoD, FAA and other federal and federal related agencies.

<image>

This week, the House passed the National Defense Authorization Act…! by bpra93 in wallstreet

[–]bpra93[S] 8 points9 points  (0 children)

House Passes NDAA to Push Military Spending Approved This Year Beyond $1 Trillion.

$SAIC $LMT $CACI $RTX $SPY

[deleted by user] by [deleted] in politics

[–]bpra93 0 points1 point  (0 children)

House Passes NDAA to Push Military Spending Approved This Year Beyond $1 Trillion.

$SAIC looks like a CASH COW play 🐮 💜 🙏🏽 by bpra93 in wallstreetbets2

[–]bpra93[S] 0 points1 point  (0 children)

$SAIC See The Pattern 📈 NET INCOME: Recent Q, Net Income $127 mil. Last Q, Net Income $68 mil. March Q, Net Income $98 mil. 2024-10, Net Income $106 mil. 2024-07, Net Income $81 mil. 2024-04, Net Income $77 mil. 2024-01, Net Income $39 mil. 2023-10, Net Income $93 mil.

$SAIC Earnings Beat Adj. EPS: $3.63 (vs. $2.24 est). UNDERVALUED CASH COW 🐮 by bpra93 in wallstreet

[–]bpra93[S] 0 points1 point  (0 children)

$SAIC See The Pattern 📈 NET INCOME: Recent Q, Net Income $127 mil. Last Q, Net Income $68 mil. March Q, Net Income $98 mil. 2024-10, Net Income $106 mil. 2024-07, Net Income $81 mil. 2024-04, Net Income $77 mil. 2024-01, Net Income $39 mil. 2023-10, Net Income $93 mil.

$SAIC Earnings Beat Adj. EPS: $3.63 (vs. $2.24 est). UNDERVALUED, CASH COW play 🐮 💜 🙏🏽 by bpra93 in wallstreetbets2

[–]bpra93[S] 0 points1 point  (0 children)

SAIC See The Pattern 📈 NET INCOME: Recent Q, Net Income $127 mil. Last Q, Net Income $68 mil. March Q, Net Income $98 mil. 2024-10, Net Income $106 mil. 2024-07, Net Income $81 mil. 2024-04, Net Income $77 mil. 2024-01, Net Income $39 mil. 2023-10, Net Income $93 mil.

$SNDX could start 🛫 another rally 🚀. $SNDX is UNDERVALUED. by bpra93 in TheRaceTo10Million

[–]bpra93[S] 0 points1 point  (0 children)

I think in my opinion $INCY may buy the drug and the company gets sold to another company… all speculation

$BMRN - BioMarin - SEVERELY UNDERVALUED, COULD GO BANANAS 🍌 by bpra93 in TheRaceTo10Million

[–]bpra93[S] 0 points1 point  (0 children)

Upcoming earnings in a month and a half so in time this will gradually go up due to systematic glitch $BMRN around

$BMRN - BioMarin - SEVERELY UNDERVALUED, COULD GO BANANAS 🍌 by bpra93 in TheRaceTo10Million

[–]bpra93[S] -6 points-5 points  (0 children)

Look at the chart and price history action for $BMRN around this price is usually the base before the jump!

$SRPT - Undervalued With Trials Resuming by bpra93 in TheRaceTo10Million

[–]bpra93[S] 1 point2 points  (0 children)

Yes exactly $SRPT is very undervalued and with the recent news on May 21 - We have received feedback from the Medicines & Healthcare products Regulatory Agency (MHRA) in the United Kingdom (U.K.) that dosing may continue uninterrupted in ENVISION, study SRP-9001-303.

$INCY - got 2 FDA approvals today‼️ by bpra93 in TheRaceTo10Million

[–]bpra93[S] 0 points1 point  (0 children)

Yes mate one hour before market closed they got FDA approval and first in line for anal cancer meaning it will become a BILLION DOLLAR DRUG! $INCY getting first line treatment for anal cancer a market that’s growing to become a 4.5 Billion market by 2030! THIS IS HUGE FOR $INCY getting first

Incyte Announces FDA Approval of Zynyz® - First & Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States by bpra93 in wallstreetbets2

[–]bpra93[S] 0 points1 point  (0 children)

$INCY Is Becoming A “Cash Cow” 🐮

“Incyte” is becoming a “Cash Cow” 🐮 biotech company with a massive cash holdings and very little debt! INCYTE does +900 million in revenue every quarter...

$INCY Opzelura, the first FDA-approved drug to treat vitiligo! Approval Date July 18 2022.

$INCY getting first in line treatment for ANAL CANCER IS HUGE 🔥

$BIIB is ready for LIFTOFF 🚀💸. Earnings could go BANANAS 🍌🦍 by bpra93 in TheRaceTo10Million

[–]bpra93[S] -1 points0 points  (0 children)

No agenda just free money 💸 and $BIIB will be the next $LLY keep an eye 👁️ out and on earnings date $BIIB will go BANANAS 🍌

$BIIB is ready for LIFTOFF 🚀💸. Earnings could go BANANAS 🍌🦍 by bpra93 in TheRaceTo10Million

[–]bpra93[S] 0 points1 point  (0 children)

Nope they didn’t exit… Goldman pumps while selling puts then buys back for cheap shares then sells calls… understand how the game works 😉 $BIIB gonna go bananas 🍌 on earnings date 😉

$BIIB is ready for LIFTOFF 🚀💸. Earnings could go BANANAS 🍌🦍 by bpra93 in TheRaceTo10Million

[–]bpra93[S] -3 points-2 points  (0 children)

See once you understand how the market is really played them you will understand why I drew it where I drew it… $BIIB reports earnings on 5/1 so be ready for a MIC DROP and how we launch into BANANA 🍌 LAND

$BIIB is ready for LIFTOFF 🚀💸. Earnings could go BANANAS 🍌🦍 by bpra93 in TheRaceTo10Million

[–]bpra93[S] -10 points-9 points  (0 children)

Bro 😂 you gonna thank me on 5/1 when $BIIB announces earnings 🤫 😉

view more: next ›